Dennis S. Yamashita
Department of Medicinal Chemistry
GlaxoSmithKline
Collegeville
USA
Name/email consistency: high
- Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors. Yamashita, D.S., Marquis, R.W., Xie, R., Nidamarthy, S.D., Oh, H.J., Jeong, J.U., Erhard, K.F., Ward, K.W., Roethke, T.J., Smith, B.R., Cheng, H.Y., Geng, X., Lin, F., Offen, P.H., Wang, B., Nevins, N., Head, M.S., Haltiwanger, R.C., Narducci Sarjeant, A.A., Liable-Sands, L.M., Zhao, B., Smith, W.W., Janson, C.A., Gao, E., Tomaszek, T., McQueney, M., James, I.E., Gress, C.J., Zembryki, D.L., Lark, M.W., Veber, D.F. J. Med. Chem. (2006)
- Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors. Yamashita, D.S., Xie, R., Lin, H., Wang, B., Shi, S.D., Quinn, C.J., Hemling, M.E., Hissong, C., Tomaszek, T.A., Veber, D.F. J. Pept. Res. (2004)
